MATTHEW MERZLOCK: Open Payments
NPI 1316985229 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,424 in 76 payments from 23 companies in 2025. Trend: 2023 $1,162 · 2024 $1,459 · 2025 $1,424
Food & beverage: $1,424
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $220 |
| Astellas Pharma US Inc | 10 | $212 |
| Vanda Pharmaceuticals Inc. | 4 | $125 |
| Antares Pharma, Inc. | 7 | $122 |
| Lilly USA, LLC | 7 | $104 |
| Phathom Pharmaceuticals, Inc. | 6 | $93 |
| Novo Nordisk Inc | 5 | $84 |
| Aimmune Therapeutics, Inc. | 4 | $83 |
| Amgen Inc. | 4 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
Products named: Veozah, FANAPT, XYOSTED, MOUNJARO, VOQUEZNA, VRAYLAR, ZENPEP, REXULTI.
Industry payments across ID — which companies pay providers there.
